Home/Filings/4/0000950170-25-036685
4//SEC Filing

Mehra Uneek 4

Accession 0000950170-25-036685

CIK 0001650648other

Filed

Mar 9, 8:00 PM ET

Accepted

Mar 10, 7:57 PM ET

Size

5.8 KB

Accession

0000950170-25-036685

Insider Transaction Report

Form 4
Period: 2025-03-06
Mehra Uneek
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-03-06+130,000130,000 total
    Exercise: $4.14Exp: 2035-03-05Common Stock (130,000 underlying)
Footnotes (1)
  • [F1]The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of March 6, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.

Documents

1 file

Issuer

4D Molecular Therapeutics, Inc.

CIK 0001650648

Entity typeother

Related Parties

1
  • filerCIK 0001881504

Filing Metadata

Form type
4
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 7:57 PM ET
Size
5.8 KB